Liebmann Edward P, Richter Kimber P, Scheuermann Taneisha, Faseru Babalola
University of Kansas, Department of Psychology, 1415 Jayhawk Blvd., Fraser Hall, Room 426, Lawrence, KS 66045, USA.
University of Kansas Medical Center, Department of Population Health, Mailstop 1008, 3901 Rainbow Blvd., Kansas City, KS 66160, USA.
Prev Med Rep. 2019 Jun 29;15:100937. doi: 10.1016/j.pmedr.2019.100937. eCollection 2019 Sep.
Numerous studies have tested the effect of multicomponent post-discharge smoking cessation interventions on post-discharge smoking cessation, and many are effective. However, little is known regarding the relative efficacy of the different intervention components on short or long-term cessation. The present study is a secondary analysis ( = 984) of a randomized controlled trial for hospitalized smokers that took place at two large hospitals in Kansas from 2011 to 2014. All study participants were offered post-discharge quitline services. Pharmacotherapy was recommended during bedside tobacco treatment. The study outcomes were self-reported cessation at 1-month and biochemically verified cessation at 6-months post-randomization. During the post-discharge period, 69% of participants completed at least one quitline call and 28% of participants reported using cessation pharmacotherapy. After controlling for known predictors of cessation among hospitalized smokers, both the number of total quitline calls completed post-discharge and use of cessation pharmacotherapy post-discharge were predictive of cessation at 1-month. After accounting for predictors of cessation and quitting at 1-month, total post-discharge quitline calls was associated with cessation at 6-months ( [95% CI] = 1.23 [1.12, 1.35], < 0.001) while post-discharge cessation pharmacotherapy use was not. The results suggest that both engagement in quitline services and use pharmacotherapy independently facilitate cessation beyond the influence of known clinical characteristics associated with cessation. Over the longer term, the effect of engaging in quitline services persists while the effect of pharmacotherapy diminishes. To optimize outcomes, future research should investigate methods to increase utilization of medications and promote sustained counseling engagement in order to sustain the effects of treatment during the post-discharge period.
许多研究检验了出院后多成分戒烟干预措施对出院后戒烟的效果,其中许多措施是有效的。然而,关于不同干预成分对短期或长期戒烟的相对疗效,人们了解甚少。本研究是对2011年至2014年在堪萨斯州两家大型医院进行的一项针对住院吸烟者的随机对照试验的二次分析(n = 984)。所有研究参与者都获得了出院后戒烟热线服务。在床边烟草治疗期间推荐了药物治疗。研究结果是随机分组后1个月的自我报告戒烟情况和6个月的生化验证戒烟情况。在出院后期间,69%的参与者至少拨打了一次戒烟热线电话,28%的参与者报告使用了戒烟药物治疗。在控制了住院吸烟者中已知的戒烟预测因素后,出院后完成的戒烟热线电话总数和出院后使用戒烟药物治疗都可预测1个月时的戒烟情况。在考虑了1个月时的戒烟预测因素和戒烟情况后,出院后戒烟热线电话总数与6个月时的戒烟情况相关([95%CI] = 1.23 [1.12, 1.35],P < 0.001),而出院后使用戒烟药物治疗则不然。结果表明,参与戒烟热线服务和使用药物治疗都能独立促进戒烟,不受与戒烟相关的已知临床特征的影响。从长期来看,参与戒烟热线服务的效果持续存在,而药物治疗的效果则逐渐减弱。为了优化结果,未来的研究应调查提高药物利用率和促进持续咨询参与的方法,以便在出院后期间维持治疗效果。